Description
SUMMARY OF PROVISIONS: Senate Bill S7694
SIGNED BY GOVERNOR 2021-2022 Legislative Session
The underlying chapter adds glucose-6-phosphate dehydrogenase deficiency(G6PDD) and adrenoleukodystrophy to the statutory list of disorders aspart of the State's Newborn Screening Program. This chapter amendment expands on the clinical scenarios that warrant G6PDD testing.
Discussion
By posting you agree to the Terms and Privacy Policy.